SOURCE: IO Circuit

December 15, 2011 07:30 ET

Cannabis Science (OTCBB: CBIS) Expanding West Into California

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by the IO CIRCUIT.

NEW YORK, NY--(Marketwire - Dec 15, 2011) - Cannabis Science, Inc. (OTCBB: CBIS), a pioneering US biotech company developing pharmaceutical cannabis products, has announced it has entered final negotiations to bring Cannabis Science brand of pharmaceutical products into California.

The medical marijuana industry is worth approximately $1.7 billion this year and could reach almost $9 billion by 2016. Currently, California and Colorado dominate the nascent industry, representing 92% of all wholesale and retail sales across the country. With nine states and the District of Columbia currently with medical marijuana laws, there are a potential 24.8 million potential patients.

Cannabis Science aims to create cannabis-based medicines, both with and without psychoactive properties, to treat disease and the symptoms of disease, as well as for general health maintenance.

Other active stocks are Powertec International (OTCBB: POWT), Sauer Energy, Inc (OTCBB: SENY) and Capstone Infrastructure Corp (PINKSHEETS: MCQPF)

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid IO Circuit twelve hundred and ninety five dollars for the publication and circulation of this news release. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation; do no trading of any kind and send no faxes or emails.

Contact Information